Composition, form of production and packaging
Tablets 1 tab.
B-190 150 mg
6 pcs. - Cellular outline packaging.
10 pieces. - packings of cellular contour - packs cardboard.
48 pcs. - Cellular outline packaging.
INSTRUCTION FOR THE SPECIALIST.
Description of the drug approved by the manufacturer for the printed edition of 2010.
B-190 refers to a 1- adrenomimetics of direct action. It has a radioprotective effect and has a great breadth of therapeutic effect.
Acceptance of the drug by a practically healthy person, both at rest and under moderate physical exertion, causes a number of characteristic effects, the main ones of which are: the pilomotor reaction (goosebumps); paresthesia in the face, scalp and upper half of the trunk; slowing heart rate; increased systolic and diastolic blood pressure. The drug has vasoconstrictive effect, increases the blood supply of the spleen and kidneys.
These pharmacodynamic effects at rest are more pronounced than with exercise; they occur in the first minutes after administration, reach a maximum of 5-30 minutes and disappear in most cases in an hour and a half after the application of the drug.
B-190, having spasmolytic activity, inhibits peristalsis and reduces intestinal tone, prevents the development of diarrhea, has no hyperglycemic properties, and has no bronchodilator effect.
Bioavailability is about 30%. C max in the blood is achieved 1-2 hours after oral administration. More than half of the injected drug is excreted by the kidneys. For a day more than 90% of the injected drug is excreted.
- as a preventive radioprotective agent in practically healthy people in emergency conditions and emergency situations when predicting the doses of radiation that cause the development of acute radiation sickness.
The preparation in the crushed form is used inside in a dose of 0.45 g (3 tab.), For 15-20 minutes before the expected irradiation. It is allowed to take the drug again with an interval of 1 hour.
When the drug is used, it is possible to increase blood pressure, decrease the pulse to 38-40 beats / min, and also AV-dissociation and AV blockade. If you experience any of the symptoms, stop taking the medication and consult a doctor.
- arterial hypertension;
- heart rhythm and conduction disorders;
- diabetes mellitus;
- organic changes in the central nervous system.
Compatible with drugs used to stop the primary reaction to radiation.
Possessing vasoconstrictive action, preparation B-190 has an effect on the absorption of drugs. He several times lengthens anesthesia caused by novocaine, but does not affect the intensity and duration of the hypnotic action of hexenal.
TERMS AND CONDITIONS OF STORAGE
List B. The drug should be stored in a dry, dark place at a temperature of no higher than 25 В°